Drug Resistance in Pneumonia (DRIP) Score
The DRIP score is a clinical tool that predicts the likelihood of drug‑resistant pathogens in community‑onset pneumonia to guide empiric antibiotic selection 1.
Indications for Use
Used for adults with community-onset pneumonia when estimating likelihood of drug‑resistant pathogens to guide empiric need for anti‑MRSA or antipseudomonal therapy. A score ≥4 identifies higher risk, helping avoid unnecessary broad‑spectrum use and reducing overtreatment by ~46% compared with HCAP criteria 1 [Level II evidence]. Validation shows AUROC ≈0.88 with NPV ≈0.90, supporting its role as a stewardship tool 1 [Level II evidence].
Insights & Cautions
Stratify risk using major predictors such as recent hospitalization or antibiotics and minor factors like chronic illness or tube feeding; higher scores identify patients more likely to harbor resistant pathogens. The score reduces unnecessary broad‑spectrum antibiotics but remains imperfect, with moderate discrimination (AUROC 0.88 in derivation 1 [Level II evidence]) and lower performance in external datasets (C‑statistic 0.63 2 [Level II evidence]). Use only alongside local epidemiology and clinical judgment.